Silvano Spinelli

SILVANO SPINELLI founded EOS S.p.A. (Ethical Oncology Science) in January 2006 and has been its Chairman and CEO until the company was acquired by Clovis Oncology, Inc in November 2013 for 470 million US Dollars. Previously Silvano was co-founder and CEO of Novuspharma. The company has its IPO in 2000 in the Italian Nuovo Mercato, collecting more than Euro 160 millions.

Novuspharma was acquired by Cell Therapeutics, Inc. (CTI) in 2003. Silvano was previously Haed of R&D at Boehringer Mannheim Italia. He holds a degree in Organic Chemistry achieved at the University of Pisa.